Compare Portfolio And Therapy Focus With Your Peers With Immunotherapy In Oncology Report
Posted on: Monday, 12 May 2008, 09:01 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c41555) has announced the addition of "Immunotherapy in Oncology: Drug Pipeline Update 2008" to their offering.
Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update the author brings together the fields of antibodies, vaccines, and immunostimulators in oncology drug development into one source.
There are today more than 850 immunotherapy drugs in oncology, from early preclinical to marketed drugs. Immunotherapy in Oncology: Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 264 different targets. These targets are further categorized on the CD-ROM by 49 classifications of molecular function and with pathway referrals to BioCarta, KEGG and NetPath. Read more below on how the Immunotherapy in Oncology: Drug Pipeline Update is organized.
How May Drug Pipeline Update Be of Use?
Show investors/board/management that you are right on top of drug development progress in your therapeutic area.
Find competitors, collaborations partners, M&A candidates etc.
Jump start competitive drug intelligence operations
Excellent starting point for world wide benchmarking
Compare portfolio and therapy focus with your peers
Speed up pro-active in-/out licensing strategy work
Fast and easy way of tracking drugs using search engines; just one click from inside the application and you may search the World Wide Web and PubMed for any drug.
Drug Pipeline Update is delivered to you as a CD-ROM application, which requires no installation on your computer. Please read more about application features and system requirements below.
Drug Pipeline Update at a Glance
Investigators Includes more than 340 principal investigators plus their collaborators. There is direct access from inside the application to web pages of all principal investigators.
For more information visit http://www.researchandmarkets.com/reports/c41555
Source: Business Wire
Related Articles
- Cyclacel Pharmaceuticals Provides Year End 2007 Pipeline Update and Outlines 2008 Key Business Objectives
- Investigate the Hepatitis B Drug Pipeline With New Report
- Renal Cancer Drug Pipeline Update Lists All Drugs and Gives You a Progress Analysis on Each One of Them
- The Colorectal Drug Pipeline Update 2007 Lists All Drugs and Gives You a Progress Analysis on Each One
- Spectrum Pharmaceuticals Announces Second Quarter 2007 Financial Results and Pipeline Update
- Spectrum Pharmaceuticals Announces Fiscal 2006 Corporate and Pipeline Update Conference Call
- Hematological Cancers Drug Pipeline Update 2006 Lists More Than 230 Drugs and Gives You a Progress Analysis on Each One of Them
- Advisory: Update on Inhalational Anthrax Investigation
- Lung Cancer Drug Pipeline Update Lists All 243 Drugs for Lung Cancer and Gives You a Progress Analysis on Each One of Them
- GlaxoSmithKline Presents Rapidly Expanding Pipeline of Oncology and Supportive Care Compounds
 |
 |
User Comments (0)
RSS Feeds